A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 13,457 shares of A stock, worth $1.72 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,457
Previous 26,614 49.44%
Holding current value
$1.72 Million
Previous $3.95 Million 54.25%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$125.69 - $146.56 $1.65 Million - $1.93 Million
-13,157 Reduced 49.44%
13,457 $1.81 Million
Q3 2024

Oct 28, 2024

BUY
$125.42 - $148.48 $1.67 Million - $1.98 Million
13,316 Added 100.14%
26,614 $3.95 Million
Q2 2024

Jul 26, 2024

BUY
$129.63 - $154.64 $19,185 - $22,886
148 Added 1.13%
13,298 $1.72 Million
Q1 2024

Apr 24, 2024

BUY
$128.12 - $149.31 $67,775 - $78,984
529 Added 4.19%
13,150 $1.91 Million
Q4 2023

Feb 09, 2024

BUY
$101.17 - $139.82 $81,644 - $112,834
807 Added 6.83%
12,621 $1.76 Million
Q3 2023

Oct 24, 2023

SELL
$109.73 - $128.47 $337,200 - $394,788
-3,073 Reduced 20.64%
11,814 $1.32 Million
Q2 2023

Jul 13, 2023

BUY
$114.69 - $141.28 $306,910 - $378,065
2,676 Added 21.91%
14,887 $1.79 Million
Q1 2023

May 11, 2023

BUY
$131.13 - $159.06 $9,965 - $12,088
76 Added 0.63%
12,211 $1.69 Million
Q4 2022

Feb 08, 2023

BUY
$125.64 - $157.68 $187,077 - $234,785
1,489 Added 13.99%
12,135 $1.82 Million
Q3 2022

Oct 17, 2022

BUY
$115.11 - $142.29 $36,950 - $45,675
321 Added 3.11%
10,646 $1.29 Million
Q2 2022

Jul 13, 2022

SELL
$112.71 - $135.93 $3.18 Million - $3.83 Million
-28,196 Reduced 73.2%
10,325 $1.23 Million
Q1 2022

May 12, 2022

SELL
$126.0 - $156.48 $21,546 - $26,758
-171 Reduced 0.44%
38,521 $5.1 Million
Q4 2021

Feb 03, 2022

BUY
$147.95 - $164.3 $102,529 - $113,859
693 Added 1.82%
38,692 $6.18 Million
Q3 2021

Nov 02, 2021

SELL
$147.58 - $179.28 $90,466 - $109,898
-613 Reduced 1.59%
37,999 $5.99 Million
Q2 2021

Aug 10, 2021

BUY
$127.69 - $148.81 $631,427 - $735,865
4,945 Added 14.69%
38,612 $5.71 Million
Q1 2021

May 07, 2021

BUY
$114.99 - $130.12 $359,918 - $407,275
3,130 Added 10.25%
33,667 $4.28 Million
Q4 2020

Feb 04, 2021

BUY
$100.01 - $119.3 $129,312 - $154,254
1,293 Added 4.42%
30,537 $3.62 Million
Q3 2020

Oct 29, 2020

BUY
$88.11 - $103.42 $1.59 Million - $1.87 Million
18,092 Added 162.23%
29,244 $2.95 Million
Q2 2020

Jul 27, 2020

SELL
$68.92 - $91.14 $182,500 - $241,338
-2,648 Reduced 19.19%
11,152 $985,000
Q1 2020

May 08, 2020

SELL
$63.37 - $90.13 $15,589 - $22,171
-246 Reduced 1.75%
13,800 $988,000
Q4 2019

Feb 04, 2020

BUY
$72.49 - $85.45 $116,201 - $136,976
1,603 Added 12.88%
14,046 $1.2 Million
Q3 2019

Nov 06, 2019

SELL
$65.59 - $78.07 $4,460 - $5,308
-68 Reduced 0.54%
12,443 $953,000
Q3 2019

Oct 28, 2019

BUY
$65.59 - $78.07 $3,476 - $4,137
53 Added 0.43%
12,511 $958,000
Q2 2019

Aug 15, 2019

BUY
$66.89 - $81.94 $7,291 - $8,931
109 Added 0.88%
12,458 $0
Q1 2019

May 08, 2019

SELL
$63.27 - $82.0 $100,093 - $129,724
-1,582 Reduced 11.36%
12,349 $0
Q4 2018

Feb 05, 2019

BUY
$61.13 - $74.67 $114,802 - $140,230
1,878 Added 15.58%
13,931 $939,000
Q3 2018

Nov 02, 2018

BUY
$61.25 - $71.13 $113,312 - $131,590
1,850 Added 18.13%
12,053 $0
Q2 2018

Aug 10, 2018

BUY
$61.14 - $69.55 $40,413 - $45,972
661 Added 6.93%
10,203 $0
Q1 2018

May 09, 2018

BUY
$65.05 - $74.82 $27,451 - $31,574
422 Added 4.63%
9,542 $0
Q4 2017

Feb 22, 2018

BUY
$64.87 - $70.59 $12,584 - $13,694
194 Added 2.17%
9,120 $0
Q3 2017

Nov 07, 2017

BUY
$58.57 - $66.17 $24,657 - $27,857
421 Added 4.95%
8,926 $573,000
Q2 2017

Aug 08, 2017

BUY
N/A
8,505
8,505 $504,000

Others Institutions Holding A

About AGILENT TECHNOLOGIES, INC.


  • Ticker A
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 296,040,992
  • Market Cap $37.9B
  • Description
  • Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...
More about A
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.